| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $150.0M | +155.3% |
| Cost of Revenue | $847K | +36.8% |
| R&D Expense | $177.2M | +6.4% |
| SG&A Expense | $71.0M | +36.1% |
| Operating Income | -$110.6M | +34.3% |
| Interest Expense | $1.1M | -22.0% |
| Pre-tax Income | -$66.0M | -628.9% |
| Income Tax | $944K | — |
| Net Income | -$67.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $182.8M | +81.1% |
| Accounts Receivable | $4.3M | -58.4% |
| Inventory | $0 | -100.0% |
| Current Assets | $217.5M | -13.5% |
| Total Assets | $261.7M | -12.3% |
| Current Liabilities | $55.5M | -1.0% |
| Total Liabilities | $145.6M | -0.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.4M | +12.6% |
| Capital Expenditures | $3.7M | +110.1% |
| Investing Cash Flow | $149.3M | +286.4% |
| Financing Cash Flow | $960K | -99.4% |
| Free Cash Flow | -$72.1M | +9.9% |
| -639.3% |
| EPS (Basic) | -$1.07 | -613.3% |
| EPS (Diluted) | -$1.07 | -613.3% |
| Stockholders' Equity |
| $116.1M |
| -24.0% |